PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.97%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
4.69%
Positive gross profit growth while 5715.T is negative. John Neff would see a clear operational edge over the competitor.
434.88%
EBIT growth above 1.5x 5715.T's 75.70%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
362.79%
Positive operating income growth while 5715.T is negative. John Neff might view this as a competitive edge in operations.
387.54%
Net income growth above 1.5x 5715.T's 103.31%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
387.81%
EPS growth above 1.5x 5715.T's 103.32%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
387.81%
Diluted EPS growth above 1.5x 5715.T's 103.32%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Share reduction while 5715.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 5715.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.55%
Negative 10Y revenue/share CAGR while 5715.T stands at 15.45%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-86.55%
Negative 5Y CAGR while 5715.T stands at 15.45%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-86.55%
Negative 3Y CAGR while 5715.T stands at 15.45%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
103.02%
Similar net income/share CAGR to 5715.T's 103.79%. Walter Schloss would see parallel tailwinds or expansions for both firms.
103.02%
5Y net income/share CAGR similar to 5715.T's 103.79%. Walter Schloss might see both on parallel mid-term trajectories.
103.02%
3Y net income/share CAGR similar to 5715.T's 103.79%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.55%
We show growth while 5715.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
11.55%
Asset growth above 1.5x 5715.T's 0.65%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.91%
BV/share growth above 1.5x 5715.T's 1.68%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
34.72%
Debt growth far above 5715.T's 1.42%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.